Rituximab Equally Effective for Remission of Vasculitis Monthly Prescribing Reference (HealthDay News) – Rituximab is as effective as conventional immunosuppressive therapy in maintaining remission in patients with severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, according to a study published in the Aug. 1 issue ... Rituximab noninferior to conventional therapy in ANCA-associated vasculitis ... |
